ALBHF (Alibaba Health Information Technology) EPS without NRI: $0.02 (TTM As of Mar. 2026)


ALBHF Alibaba Health Information Technology Ltd ALBHF
55 GF Score
Price $0.42
GF Value $0.63
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology EPS without NRI?

Alibaba Health Information Technology ALBHF 55 EPS without NRI is $0.02 as of Mar. 2026. GuruFocus rates ALBHF with a GF Score™ of 55/100 and a GF Value™ of $0.63 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks better than 91.8% on this metric.

Alibaba Health Information Technology's earnings per share without non-recurring items for the six months ended in Mar. 2026 was $0.01. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $0.02.

During the past 12 months, Alibaba Health Information Technology's average earnings per share (NRI) Growth Rate was 21.70% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 59.50% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Alibaba Health Information Technology's EPS without NRI or its related term are showing as below:

ALBHF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -166.8   Med: 9.3   Max: 61.8
Current: 59.5

During the past 13 years, Alibaba Health Information Technology's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 61.80% per year. The lowest was -166.80% per year. And the median was 9.30% per year.

ALBHF's 3-Year EPS without NRI Growth Rate is ranked better than
91.8% of 512 companies
in the Healthcare Providers & Services industry
Industry Median: 11.55 vs ALBHF: 59.50

Alibaba Health Information Technology's EPS (Diluted) for the six months ended in Mar. 2026 was $0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.02.

Alibaba Health Information Technology's EPS (Basic) for the six months ended in Mar. 2026 was $0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.02.


Alibaba Health Information Technology  (OTCPK:ALBHF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Alibaba Health Information Technology EPS without NRI Related Terms


Alibaba Health Information Technology EPS without NRI Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology EPS without NRI Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 0.01 0.01 0.02 0.02

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Alibaba Health Information Technology EPS without NRI Competitor Comparison

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alibaba Health Information Technology PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's PE Ratio without NRI falls into.


ALBHF
55GF Score
Alibaba Health Information Technology Ltd ALBHF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alibaba Health Information Technology EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.02 mean?
Alibaba Health Information Technology (ALBHF) has a EPS without NRI of $0.02 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Alibaba Health Information Technology and its competitors. According to the industry distribution chart, Alibaba Health Information Technology ranks #42 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 8.2%.
Is Alibaba Health Information Technology's EPS without NRI too high?
Alibaba Health Information Technology's current EPS without NRI is $0.02. The Healthcare Providers & Services industry median EPS without NRI is 11.55. Alibaba Health Information Technology's value of $0.02 is 99.8% below this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #42 out of 512 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alibaba Health Information Technology has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's EPS without NRI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #42 out of 512 companies for EPS without NRI. This places Alibaba Health Information Technology in the top 8% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 11.55. Alibaba Health Information Technology's value of $0.02 is 99.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.55, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current EPS without NRI of $0.02 is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current EPS without NRI is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.63, compared to a current price of $0.42 — trading 33.3% below its estimated fair value. The current EPS without NRI is $0.02 and 99.8% below the Healthcare Providers & Services industry median of 11.55. Alibaba Health Information Technology's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current EPS without NRI is $0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of $0.42 is trading 33.3% below its estimated GF Value™ of $0.63. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for ALBHF:

  • EPS without NRI: $0.02
  • GF Value™: $0.63 vs. price of $0.42 (33.3% below fair value)
  • GF Score™: 55/100 with 2 warning signs
  • Industry Position: 99.8% below the Healthcare Providers & Services median (#42 of 512)

No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
55GF Score

Get the complete analysis for ALBHF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price
$0.63
GF Value